BlackRock Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $225K | Sell |
10,855
-493
| -4% | -$10.2K | ﹤0.01% | 2607 |
|
|
2016
Q3 | $184K | Buy |
11,348
+1,546
| +16% | +$25.1K | ﹤0.01% | 2668 |
|
|
2016
Q2 | $133K | Buy |
9,802
+1,338
| +16% | +$18.2K | ﹤0.01% | 2767 |
|
|
2016
Q1 | $148K | Buy |
8,464
+615
| +8% | +$10.8K | ﹤0.01% | 2665 |
|
|
2015
Q4 | $268K | Sell |
7,849
-2,103
| -21% | -$71.8K | ﹤0.01% | 2367 |
|
|
2015
Q3 | $296K | Buy |
9,952
+154
| +2% | +$4.58K | ﹤0.01% | 2473 |
|
|
2015
Q2 | $313K | Buy |
9,798
+4,325
| +79% | +$138K | ﹤0.01% | 2475 |
|
|
2015
Q1 | $113K | Buy |
5,473
+561
| +11% | +$11.6K | ﹤0.01% | 2952 |
|
|
2014
Q4 | $83K | Hold |
4,912
| – | – | ﹤0.01% | 3095 |
|
|
2014
Q3 | $95K | Sell |
4,912
-53,670
| -92% | -$1.04M | ﹤0.01% | 2999 |
|
|
2014
Q2 | $1.99M | Buy |
58,582
+8,916
| +18% | +$303K | ﹤0.01% | 1153 |
|
|
2014
Q1 | $1.56M | Buy |
+49,666
| New | +$1.56M | ﹤0.01% | 1260 |
|